1. Home
  2. SSB vs HALO Comparison

SSB vs HALO Comparison

Compare SSB & HALO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SouthState Corporation

SSB

SouthState Corporation

HOLD

Current Price

$108.89

Market Cap

9.9B

Sector

Finance

ML Signal

HOLD

Logo Halozyme Therapeutics Inc.

HALO

Halozyme Therapeutics Inc.

HOLD

Current Price

$82.62

Market Cap

8.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SSB
HALO
Founded
1933
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.9B
8.1B
IPO Year
2008
2001

Fundamental Metrics

Financial Performance
Metric
SSB
HALO
Price
$108.89
$82.62
Analyst Decision
Strong Buy
Buy
Analyst Count
13
11
Target Price
$118.00
$78.64
AVG Volume (30 Days)
819.5K
1.6M
Earning Date
04-23-2026
05-05-2026
Dividend Yield
2.49%
N/A
EPS Growth
12.91
N/A
EPS
4.64
1.22
Revenue
N/A
$151,862,000.00
Revenue This Year
$10.07
$28.24
Revenue Next Year
$6.51
$12.56
P/E Ratio
$23.53
$68.52
Revenue Growth
N/A
N/A
52 Week Low
$84.48
$61.23
52 Week High
$110.47
$84.44

Technical Indicators

Market Signals
Indicator
SSB
HALO
Relative Strength Index (RSI) 69.83 68.80
Support Level $92.40 $67.63
Resistance Level N/A $84.44
Average True Range (ATR) 1.98 1.93
MACD 0.43 0.08
Stochastic Oscillator 90.87 97.52

Price Performance

Historical Comparison
SSB
HALO

About SSB SouthState Corporation

SouthState Bank Corp is a United States-based bank holding company. It provides a wide range of services and products to its customers through a wholly-owned bank subsidiary. The Bank provides retail and commercial banking services, mortgage lending services, trust and investment services, and consumer finance loans through financial centers in Alabama, Florida, Georgia, North Carolina, South Carolina, and Virginia. These services include demand, time, and savings deposits, lending and credit card servicing, ATM processing, and wealth management and trust services.

About HALO Halozyme Therapeutics Inc.

Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. ENHANZE drug delivery technology was introduced with the proprietary enzyme rHuPH20, to facilitate the subcutaneous delivery of injected drugs and fluids, with the goal of improving the patient experience with rapid SC delivery and reduced treatment burden. The company's operations are based in the United States, with minimal long-lived assets located internationally.

Share on Social Networks: